BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16831592)

  • 1. Clinical and therapeutic implications of hepatitis C virus compartmentalization.
    Di Liberto G; Roque-Afonso AM; Kara R; Ducoulombier D; Fallot G; Samuel D; Feray C
    Gastroenterology; 2006 Jul; 131(1):76-84. PubMed ID: 16831592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C.
    Pawlotsky JM; Pellerin M; Bouvier M; Roudot-Thoraval F; Germanidis G; Bastie A; Darthuy F; Rémiré J; Soussy CJ; Dhumeaux D
    J Med Virol; 1998 Apr; 54(4):256-64. PubMed ID: 9557291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
    Yu ML; Chuang WL; Dai CY; Lee LP; Hsieh MY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Tsai SL; Kuo HT
    Transl Res; 2006 Sep; 148(3):120-7. PubMed ID: 16938649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between translation efficiency and outcome of combination therapy in chronic hepatitis C genotype 3.
    Yasmeen A; Hamid S; Granath FN; Lindström H; Elliott RM; Siddiqui AA; Persson MA
    J Viral Hepat; 2006 Feb; 13(2):87-95. PubMed ID: 16436126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus genetic variability in 52 human immunodeficiency virus-coinfected patients.
    Neau D; Jouvencel AC; Legrand E; Trimoulet P; Galperine T; Chitty I; Ventura M; Le Bail B; Morlat P; Lacut JY; Ragnaud JM; Dupon M; Fleury H; Lafon ME
    J Med Virol; 2003 Sep; 71(1):41-8. PubMed ID: 12858407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid virologic response: a new milestone in the management of chronic hepatitis C.
    Poordad F; Reddy KR; Martin P
    Clin Infect Dis; 2008 Jan; 46(1):78-84. PubMed ID: 18171217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus quasispecies in plasma and peripheral blood mononuclear cells of treatment naïve chronically infected patients.
    Vera-Otarola J; Barría MI; León U; Marsac D; Carvallo P; Soza A; López-Lastra M
    J Viral Hepat; 2009 Sep; 16(9):633-43. PubMed ID: 19254350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of hepatitis C virus (HCV)-RNA in peripheral blood mononuclear cells in HCV serum negative patients during interferon and ribavirin therapy.
    Januszkiewicz-Lewandowska D; Wysocki J; Pernak M; Nowicka K; Zawada M; Rembowska J; Lewandowski K; Mańkowski P; Nowak J
    Jpn J Infect Dis; 2007 Feb; 60(1):29-32. PubMed ID: 17314422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response.
    Landau DA; Saadoun D; Halfon P; Martinot-Peignoux M; Marcellin P; Fois E; Cacoub P
    Arthritis Rheum; 2008 Feb; 58(2):604-11. PubMed ID: 18240235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.
    Zografos TA; Liaskos C; Rigopoulou EI; Togousidis E; Makaritsis K; Germenis A; Dalekos GN
    Am J Gastroenterol; 2008 Mar; 103(3):605-14. PubMed ID: 18190648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship between diversity of hepatitis C virus quasispecies and viremia, activity of liver disease and response to interferon therapy].
    Tang X; Qian K; Yuan X; Johnson YN
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun; 16(2):128-31. PubMed ID: 12196822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of hepatitis C virus in platelets: evaluating its relationship to antiviral therapy outcome.
    de Almeida AJ; Campos-de-Magalhães M; Brandão-Mello CE; de Oliveira RV; do Espirito-Santo MP; Yoshida CF; Lampe E
    Hepatogastroenterology; 2009; 56(90):429-36. PubMed ID: 19579615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clearance of HCV RNA in peripheral blood mononuclear cell as a predictor of response to antiviral therapy in patients with chronic hepatitis C.
    Xu DZ; Xie Y; Li ZQ
    Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):550-3. PubMed ID: 16286260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virological effects of ISIS 14803, an antisense oligonucleotide inhibitor of hepatitis C virus (HCV) internal ribosome entry site (IRES), on HCV IRES in chronic hepatitis C patients and examination of the potential role of primary and secondary HCV resistance in the outcome of treatment.
    Soler M; McHutchison JG; Kwoh TJ; Dorr FA; Pawlotsky JM
    Antivir Ther; 2004 Dec; 9(6):953-68. PubMed ID: 15651754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replication of hepatitis C virus in ascitic mononuclear cells with development of distinct viral quasispecies.
    Hsu CW; Yeh CT; Chen PG; Liaw YF
    J Infect Dis; 1999 Oct; 180(4):992-1000. PubMed ID: 10479123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for a relation between the viral load and genotype and hepatitis C virus-specific T cell responses.
    Hultgren C; Desombere I; Leroux-Roels G; Quiroga JA; Carreno V; Nilsson B; Weiland O; Sällberg M
    J Hepatol; 2004 Jun; 40(6):971-8. PubMed ID: 15158338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compartmentalization of hepatitis C virus genotypes between plasma and peripheral blood mononuclear cells.
    Roque-Afonso AM; Ducoulombier D; Di Liberto G; Kara R; Gigou M; Dussaix E; Samuel D; Féray C
    J Virol; 2005 May; 79(10):6349-57. PubMed ID: 15858018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent compartmentalization of hepatitis C virus variants in circulating B cells and monocytes.
    Ducoulombier D; Roque-Afonso AM; Di Liberto G; Penin F; Kara R; Richard Y; Dussaix E; Féray C
    Hepatology; 2004 Mar; 39(3):817-25. PubMed ID: 14999702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypervariable region 1 of hepatitis C virus genome and response to interferon therapy.
    Grahovac B; Bingulac-Popović J; Vucelić B; Hrstić I; Ostojić R; Drazić V; Balija M; Grgicević D
    Clin Chem Lab Med; 2000 Sep; 38(9):905-10. PubMed ID: 11097348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.